Hormonal and neurochemical changes in menopause and chronic headaches: A conceptual model

Headache Quarterly

Volumn 7, Issue 4, 1996, Pages 294-305

  Marcus, Dawn A ^a,b   Scharff, Lisa ^a   Turk, Dennis C ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

estrogen; headache; Menopause

Indexed keywords

CONJUGATED ESTROGEN; ESTRADIOL; ESTROGEN; GESTAGEN;

ADULT; AGED; CLINICAL TRIAL; ESTROGEN BLOOD LEVEL; ESTROGEN THERAPY; FEMALE; HEADACHE; HORMONAL REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MENOPAUSAL SYNDROME; META ANALYSIS; NEUROCHEMISTRY; PRIORITY JOURNAL; REVIEW; SOCIAL PSYCHOLOGY;

EID: 0030454089     PISSN: 10597565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (90)

1. Abraham S, Llewellyn-Jones D, Perz J. Changes in Australian women's perception of the menopause and menopausal symptoms before and after the climacteric. Maturitas. 1995; 20:121-128.
2. Anderson E, Hamburger S, Liu JH, Rebar RW. Characteristics of menopausal women seeking assistance. Am J Obstet Gynecol. 1987; 156:428-433.
3. Andrasik F, Blanchard EB, Arena JG, Teders SJ, Teevan RC, Rodichok LD. Psychological functioning in headache sufferers. Psychosom Med. 1982; 171-182.
4. Anthony M, Hinterberger H, Lance JW. Plasma serotonin in migraine and stress. Arch Neurol. 1967; 16:544-552.
5. Avis NE, Kaufert PA, Lock M, McKinlay SM, Vass K.The evolution of menopausal symptoms. Bailliere's Clin Endocrin Metab. 1993; 7:17-32.
6. _ McKinlay SM. The Massachusetts Women's Health Study: An epidemiological investigation of the menopause. JAMWA. 1995; 50:45-49.
7. Aylward M, Holly F, Parker RJ. An evaluation of clinical response to piperazine oestrone ('Harmogen') in menopausal patients. Curr Med Res Opinion. 1974; 2:417-423.
8. Ballinger SE. Psychosocial stress and symptoms of menopause: A comparative study of menopause clinic patients and nonpatients. Maturitas. 1985; 7:315-327.
9. Bank J. Brainstem auditory evoked potentials in migraine after Rausedyl Provocation. Cephalalgia. 1991; 11:277-279.
10. Baranowska B. The effect of clonidine on pituitary hormone secretion in physiological and pathological states. J Cardiovas Pharmacol. 1987; 10(suppl 12):S235-S239.
11. Barclay SR, Harding CF. Differential modulation of monoamine levels and turnover rates by estrogen and/or androgens in hypothalamic and vocal control neurons of male zebra finches. Brain Res. 1990; 523:251-262.
12. Bartelink ML, van de Lisdonk E, van den Hoogen H, Wollersheim H, van Weel C. Migraine in family practice: Prevalence and influence of sex hormonal status. Fam Med. 1993; 25:331-336.
13. Bergmans MM, Merkus JM, Corbey RS, Schellekens LA, Ubachs JH. Effect of Bellergal Retard on climacteric complaints: A double-blind, placebo-controlled study. Maturitas. 1987; 9:227-234.
14. Bono G, Neri I, Granella F, Genazzani AR, Facchinetti F. Factors associated with pain complaints in a clinical sample of postmenopausal women. J Psychosom Obstet Gynecol. 1995; 16:117-121.
15. Brewerton TD, Murphy DL, Mueller EA, Jimerson DC. Induction of migraine-like headaches by the serotonin agonist m-chlorophenylpiperazine. Clin Pharmacol Ther. 1988; 43:605-609.
16. Bungay GT, Vessey MP, McPherson CK. Study of symptoms in middle life with special reference to the menopause. Br Med J. 1980; 19:181-183.
17. Busch CM, Zonderman AB, Costa PT. Menopausal transition and psychological distress in a nationally representative sample: Is menopause associated with psychological distress? J Aging Health. 1994; 6:209-228.
18. Condon TP, Ronnekleiv UK, Kelly MJ. Estrogen modulation of alpha-1-adrenoreceptors of hypothalamic neurons. Neuroendocrinology. 1989; 50:51-58.
19. Cooke NR, Evans DA, Funkenstien HH, Scherr PA, Ostfeld AM, Taylor JO, et al. Correlates of headache in a population-based cohort of elderly. Arch Neurol. 1989; 46:1338-1344.
20. Coope J, Thomson JM, Poller L. Effects of "natural oestrogen" replacement therapy on menopausal symptoms and blood clotting. Br Med J. 1975; 4:139-143.
21. Cupini LM, Matteis M, Troisi E, Calabresi P, Bernardi G, Silvestrini M. Sex hormone-related events in migrainous females. A clinical comparative study between migraine with aura and migraine without aura. Cephalalgia. 1995; 15:140-144.
22. Curran DA, Hinterberger H, Lance JW. Total plasma serotonin, 5-hydroxyindoleacetic acid and p-hydroxy-m-methoxymandelic acid excretion in normal and migrainous subjects. Brain. 1965; 88:997-1009.
23. D'Andrea G, Welch KM, Nagel-Leiby S, Greenfeld S, Joseph R. Platelet catecholamines in migraine. Cepahalgia. 1989; 9:3-5.
24. Dawson TM, Dawson VL, Snyder SH. A novel neuronal messenger molecule in the brain: The free radical, nitric oxide. Ann Neurol. 1992; 32:297-311.
25. _Molecular mechanisms of nitric oxide actions in the brain. Ann NY Acad Sci. 1994; 738:76-85.
26. De Benedittis G, Lorenzetti A. The role of stressful life events in the persistence of primary headache: Major events vs. daily hassles. Pain. 1992; 51:35-42.
27. Dennerstein L, Laby B, Burrows GD, Hyman GJ. Headache and sex hormone therapy. Headache. 1978; 18:146-153.
28. Desan PH, Woodmansee WW, Ryan SM, Smock TK, Maier SF. Monoamine neurotransmitters and metabolites during the estrous cycle, pregnancy, and the postpartum period. Pharmacol Biochem Behav. 1988; 30:563-568.
29. Erlik Y, Meldrum DR, Judd HL. Estrogen levels in postmenopausal women with hot flashes. Ob Gyn. 1982; 59:403-407.
30. Facchinetti F, Sternieri E, Nappi G, Alessandrinin G, Jannopulu M, Morgillo MG, et al. Clinical findings of headache in postmenopausal age. In: Postmenopausal Hormonal Therapy: Benefits and Risks. (Fioretti P, Flamigni C, Jasonni VM, Melis GB, eds). New York; Raven Press: 1987; 67-70.
31. Flint M. The menopause: Reward or punishment? Psychosomatics. 1975; 16:161-163.
32. Fog-Moller F, Genefke IK, Bryndum B. Changes in concentration of catecholamines in blood during spontaneous migraine attacks and reserpine-induced attacks. In: Current Concepts in Migraine Research (Greene R, ed). New York; Raven Press; 1978; 115-119.
33. Gallai V, Gaiti A, Sarchielli P, Coata G, Trequathrini A, Paciaroni M. Evidence for an altered dopamine-Beta-hydroxylase activity in migraine and tension-type headaches. Acta Neurol Scand. 1992; 86:403-406.
34. Goadsby PJ, Lance JW. Physiopathology of migraine. Rev Du Prat. 1990; 40:389-393.
35. Goetz RM, Morano I, Calovini T, Studer R, Holtz J. Increased expression of endothelial constitutive nitric oxide synthetase in rat aorta during pregnancy. Biochem Biophys Res Comm. 1994; 205:905-910.
36. Gonzales GF, Carrillo C. Blood serotonin levels in postmenopausal women: Effects of age and serum oestradiol levels. Maturitas. 1993; 17:23-29.
37. Granella F, Sances G, Zanferrari C, Costa A, Martignomi E, Manzoni GC. Migraine without aura and reproductive life events: A clinical epidemiological study in 1300 women. Headache. 1993; 33:385-389.
38. Greenblatt RB, Bruneteau DW. Menopausal headache - Psychogenic or metabolic? J Am Geriat Soc. 1974; 22:186-190.
39. Greene JG, Cooke DJ. Life stress and symptoms at the climacterium. Br J Psychiatry. 1980; 136:486-491.
40. Henderson S, Jorm AF, Scott L'R, Mackinnon AJ, Christensen H, Korten AE. Insomnia in the edlerly: Its prevalence and correlates in the general population. Med J Austral. 1995; 162:22-24.
41. Heritage S, Stumpf WE, Sar M, Grant L. Brainstem catecholamine neurons are target sites for sex steroid hormones. Science. 1980; 207:1377-1379.
42. Holte A. Influences of natural menopause on health complaints: A prospective study of healthy Norwegian woman. Maturitas. 1992; 14:127-141.
43. _Mikkelsen A. Psychosocial determinants of climacteric complaints. Maturitas. 1991; 13:205-215.
44. Honkasalo ML, Kaprio J, Heikkila K, Sillanpaa M, Kaskenvuo M. A population-based survey of headache and migraine in 22,809 adults. Headache. 1993; 33:403-412.
45. Ignarro LJ, Lippton H, Edwards JC, Baricos WH, Hyman AL, Kadowitz PJ, et al. Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrides, nitroprusside and nitric oxide: Evidence for the involvement of S-Nitrosothiols as active intermediates. J Pharmacol Exp Ther. 1981; 218:739-749.
46. Ikeda T, Ikenoue T. Influence of pregnancy on the vascular response to norepinephrine and serotonin in rat carotid artery. Acta Obstet Gynecol Jap. 1994; 46:240-246.
47. Jazmann L, van Lith ND, Zaat JLA. The perimenopausal symptoms: The statistical analysis of a survey. Med Gynaecol Sociol. 1969; 4:268-277.
48. Johannes CB, Linet MS, Stewart WF, Celentano DD, Lipton RB, Szklo M. Relationship of headache to phase of the menstrual cycle among young women: A daily diary study. Neurology. 1995; 45:1076-1082.
49. Kaiser HJ, Meienberg O. Deterioration or onset of migraine under oestrogen replacement therapy in the menopause. J Neurol. 1993; 240:195-197.
50. Khan SA, Pace JE, Cox ML, Gau DW, Cox SL, Hodkinson HM. Climacteric symptoms in healthy middle-aged women. Br J Clin Prac. 1994; 48:240-242.
51. Kimball RW, Friedman AP, Vallejo E. Effect of serotonin in migraine patients. Neurology. 1960; 10:107-111.
52. Koster A, Davidsen M. Climacteric complaints and their relation to menopausal development - A retrospective analysis. Maturitas. 1995; 17:155-166.
53. Kudrow L. The relationship of headache frequency to hormone use in migraine. Headache. 1975; 15:36-50.
54. MacGregor EA, Blau JN. Migraine: An informative method of communication. Headache. 1992; 32:356-359.
55. Mani SK, Allen JM, Rettori V, McCamm SM, O'Malley BW, Clark JH. Nitric oxide mediates sexual behavior in female rats. Proc Nat Acad Sci US. 1994; 91:6468-6472.
56. Marcus DA. Serotonin and its role in headache pathogenesis and treatment. Clin J Pain. 1993; 9:159-167.
57. _Interrelationships of neurochemicals, estrogen, and recurring headache. Pain. 1995; 62:129-139.
58. Martin PL, Burnier AM, Segre EJ, Huix FJ. Graded sequential therapy in the menopause: A double-blind study. Am J Obstet Gynecol. 1971; 111:178-186.
59. Matthews KA, Wing RR, Kuller LH, Meilahn EN, Kelsey SF. Influences of natural menopause on psychological characteristics and symptoms of middle-aged healthy women. J Consult Clin Psychol. 1990; 58:345-351.
60. _Kuller LH, Wing RR, Meilahn EN. Biobehavioral aspects of menopause: Lessons from the healthy women study. Exper Gerontol. 1994; 29:337-342.
61. Meller ST, Gebhart GF. Nitric oxide (NO) and nociceptive processing in the spinal cord. Pain. 1993; 52:127-136.
62. Mendelsohn ME, Karas RH. Estrogen and the blood vessel wall. Curr Opin Cardiol. 1994; 9:619-626.
63. Miller VM, Vanhoutte PM. 17 beta-Estradiol augments endothelium-dependent contractions to arachidonic acid in rabbit aorta. Am J Physiol. 1990; 258:R1502-1507.
64. Moncada S, Palmer RJ, Higgs EA. Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol Rev. 1991;43:109-142.
65. Monjan AA, Bellino FL, Dry MG, Sherman S, Weiss S. Session VI: Research directions. Research recommendations. Expr Gerontol. 1994; 29:525-528.
66. Moskowitz MA. The neurobiology of vascular head pain. Ann Neurol. 1984; 16:157-168.
67. Muck AO, Seegar H, Korte K, Haais R, Lippert TH. Does estradiol modify the NO/cGMP system of blood vessels? Studies of the mechanism of cardiovascular protection by estrogen substitution in the postmenopausal period. Zentralblatt Gynakologie. 1994; 116:507-511.
68. Nagamani M, Kelver ME, Smith ER. Treatment of menopausal hot flashes with transdermal administration of clonidine. Am J Obstet Gynecol. 1987; 156:561-565.
69. Neri I, Granella F, Nappi R, Manzoni GC, Facchinetti F, Genazzani AR. Characteristics of headache at menopause: A clinico epidemiological study. Maturitas. 1993; 17:31-37.
70. Olesen J, Iversen HK, Thomasen LL. Nitric oxide supersensitivity: A possible molecular mechanism of migraine pain. NeuroReport. 1993; 4:1027-1030.
71. _Thomsen LL, Iversen H. Nitric oxide is a key molecule in migraine and other vascular headaches. Trends Pharmacol Sci. 1994; 15:149-153.
72. Pansini F, Albertazzi P, Bonaccorsi G, Calisesi M, Campobasso C, Zanotti L, et al. The menopausal transition: A dynamic approach to the pathogenesis of neurovegetative complaints. Eur J Obstet Gynecol Reproduc Biol. 1994;57:103-109.
73. Rand MJ. Nitrergic transmission: Nitric oxide as a mediator of non-adrenergic, non-cholinergic neuro-effector transmission. Clin Exp Pharmacol Physiol. 1992; 19:147-169.
74. Report of a WHO scientific Group. Research on the menopause. In: Who Technical Report, series 670. Geneva; 1981.
75. Rolf LH, Wiele G, Brune GG. 5-hydroxytryptamine in platelets of patients with muscle contraction headache. Headache. 1981;21:10-11.
76. Rosselli M, Imthurm B, Macas E, Keller PJ, Dubey RK. Circulating nitrite/nitrate levels increase with follicular development: Indirect evidence for estradiol mediated NO release. Biochem Biophysi Res Comm. 1994; 202:1543-1552.
77. Rybo G, Westerberg H. Symptoms in the postmenopause: A population study. Acta Obstet Gynaecol Scand. 1971; 30:25.
78. Shay J, Futo J, Badrov N, Moss J. Estrogen withdrawal selectively increases serotonin reactivity in rabbit basilar artery. Life Sci. 1994;55:1071-1081.
79. Shimizu H, Bray GA. Effects of castration, estrogen replacement and estrus cycle on monoamine metabolism in the nucleus accumbens, measured by microdialysis. Brain Res. 1993; 62:200-206.
80. Somerville BW. Estrogen-withdrawal migraine. I. Duration of exposure required and attempted prophylaxis by premenstrual estrogen administration. Neurology. 1975; 25:239-244.
81. Stewart W, Lipton R, Celentano D, Reed M. Prevalence of migraine headache in the United States. JAMA. 1992; 267:64-69.
82. Stone EA. Stress and catecholamines. In: Catecholamines and Behavior (Friedhoff AJ, ed). New York; Plenum Press; 1975; 74-79.
83. Tannock C, Katona C. Minor depression in the aged. Concepts, prevalence and optimal management. Drugs Aging. 1995; 6:278-292.
84. Trevoux R, DeBrux J, Grenier J, Roger M, Bailleul S, Schollar R. Etude histo-hormonale de 399 perimenopauses et menopauses confirmees. J Gyn Obstet Biol Repro. 1979; 8:13-22.
85. Utian WH. Oestrogen, headache and oral contraceptives. S Afr Med J. 1974; 48:2105-2108.
86. Van Leusden HM, Albertyn G, Verlaine C, Van Ruymbeke J. A comparative multicenter study of two transdermal estradiol replacement therapies in the treatment of postmenopausal symptoms, Int J Fertil. 1993; 38:210-218.
87. Wagner HR, Crutcher KA, Davis JN. Chronic estrogen treatment decreases beta-adrenergic responses in rat cerebral cortex. Brain Res. 1979; 171:147-151.
88. Whitty CM, Hockaday JM. Migraine: A follow-up study of 92 patients. Br Med J. 1968; 1:735-736.
89. Yallampalli C, Byam-Smith M, Nelson SO, Garfield RE. Steroid hormones modulate the production of nitric oxide and cGMP in the rat uterus. Endocrinology. 1994; 134:1971-1974.
90. Zorn JR, Boyer A, Guichard A. Never on a Sunday: Programming for IVF-ET and GIFT. Lancet. 1987; 1:385-386.